Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYP3A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CBX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YPEL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRUNE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00467 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WAC-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF2AK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIN1P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPNS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRTAP10-11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on